Increased Expression of Mitotic Checkpoint Genes in Breast Cancer Cells with Chromosomal Instability
暂无分享,去创建一个
Ju-Hyung Woo | E. Gabrielson | R. Wersto | E. Tully | J. Woo | Y. Bae | Yi Xu | Edward Gabrielson | Yi Xu | Young Kyung Bae | Robert P. Wersto | Ellen Tully | Yunyue Wang | Bibo Yuan | Dae-Sung Yoon | Kathleen Wilsbach | Bibo Yuan | Yunyue Wang | Dae-Sung Yoon | K. Wilsbach
[1] Bert Vogelstein,et al. Mutations of mitotic checkpoint genes in human cancers , 1998, Nature.
[2] R. Goorha,et al. The mouse mitotic checkpoint gene bub1b, a novel bub1 family member, is expressed in a cell cycle-dependent manner. , 1999, Genomics.
[3] E. Petty,et al. Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells , 2000, Genes, chromosomes & cancer.
[4] E. Petty,et al. Mutation and expression analysis of human BUB1 and BUB1B in aneuploid breast cancer cell lines. , 2000, Cancer letters.
[5] W. Gerald,et al. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells , 2001, Nature.
[6] R. Barkardottir,et al. Mutation analysis of the CHK2 gene in breast carcinoma and other cancers , 2001, Breast Cancer Research.
[7] A. Yoshimura,et al. Genomic structure of the human MAD2 gene and mutation analysis in human lung and breast cancers. , 2001, Lung cancer.
[8] R. C. Johnston,et al. Distinct chromosome segregation roles for spindle checkpoint proteins. , 2002, Molecular biology of the cell.
[9] S. Tsao,et al. Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. , 2002, Cancer research.
[10] R. Barkardottir,et al. Mutation analysis of the CHK 2 gene in breast carcinoma and other cancers , 2002 .
[11] M. Shichiri,et al. Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. , 2002, Cancer research.
[12] Carl W. Miller,et al. Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors , 2002, Genes, chromosomes & cancer.
[13] E. Gabrielson,et al. Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer. , 2002, The American journal of pathology.
[14] Wenge Lu,et al. hBUB1 defects in leukemia and lymphoma cells , 2002, Oncogene.
[15] F. McKeon,et al. Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability. , 2003, Cancer cell.
[16] C. Perou,et al. Cell-Type-Specific Responses to Chemotherapeutics in Breast Cancer , 2004, Cancer Research.
[17] Geert J P L Kops,et al. Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[18] E. Gabrielson,et al. Mucinous Cancers have Fewer Genomic Alterations than More Common Classes of Breast Cancer , 2002, Breast Cancer Research and Treatment.
[19] R. Mahmood,et al. Slippage of Mitotic Arrest and Enhanced Tumor Development in Mice with BubR1 Haploinsufficiency , 2004, Cancer Research.
[20] Yudong D. He,et al. A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. , 2005, Cancer research.
[21] Roman Rouzier,et al. Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy , 2005, Clinical Cancer Research.
[22] M. Stampfer,et al. Growth of normal human mammary cells in culture , 1980, In Vitro.